Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 100% increase over the number of companies cited in the previous month.
The citations in the county were 'Written procedures have not been developed for the surveillance, receipt and evaluation of post marketing adverse drug experiences' and 'Procedures for corrective and preventive action have not been adequately established'.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Bajaj Medical, LLC | Drugs | 12/04/2024 | Failure to develop written procedures |
Sterigenics International, LLC | Devices | 12/17/2024 | Lack of or inadequate procedures |